Please check your internet connection and try again.
# Sompraz hp
## Overview
Sompraz hp is a fixed-dose combination product containing pantoprazole, amoxicillin, and clarithromycin. It is used for the eradication of *Helicobacter pylori* infection.
## Primary Indications
* Eradication of *Helicobacter pylori* in patients with peptic ulcer disease.
## Adult Dosing
* **Standard Regimen:** One capsule (containing pantoprazole 40 mg, amoxicillin 500 mg, and clarithromycin 500 mg) taken twice daily for 7 to 14 days. The exact duration depends on local guidelines and treatment success.
## Pediatric Dosing
* Pediatric dosing is not well-established for this specific combination product. Dosing should be individualized based on age, weight, and renal/hepatic function, typically using separate components if necessary.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustment for the combination product. However, amoxicillin dosage may need reduction in severe renal impairment. Clarithromycin dose should be reduced in severe renal impairment (CrCl < 30 mL/min). Pantoprazole generally does not require dose adjustment.
* **Hepatic Impairment:** No specific dose adjustment for the combination product. However, caution is advised with clarithromycin in hepatic impairment.
## Contraindications
* Hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or other macrolides, penicillins, or proton pump inhibitors.
* History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
* Concomitant use with ergotamine or dihydroergotamine.
* Severe renal impairment with co-administration of clarithromycin and colchicine.
## Adverse Effects
* **Common:** Diarrhea, nausea, abdominal pain, headache, taste disturbance, rash.
* **Serious:** *Clostridioides difficile*-associated diarrhea, severe allergic reactions (anaphylaxis), Stevens-Johnson syndrome, toxic epidermal necrolysis, liver dysfunction, QT prolongation (clarithromycin), *C. difficile* infection.
## Key Drug Interactions
* **Clarithromycin:** May increase plasma concentrations of CYP3A4 substrates (e.g., warfarin, carbamazepine, simvastatin, lovastatin, cyclosporine, tacrolimus, colchicine, some calcium channel blockers). Avoid concomitant use with colchicine in renal or hepatic impairment. May interact with statins.
* **Pantoprazole:** May decrease absorption of drugs requiring acidic environments (e.g., ketoconazole, itraconazole, certain HIV protease inhibitors). May affect absorption of vitamin B12. May interact with methotrexate.
* **Amoxicillin:** May decrease the efficacy of oral contraceptives.
## Monitoring
* Monitor for signs and symptoms of *C. difficile*-associated diarrhea.
* Monitor for signs of hypersensitivity reactions.
* Monitor liver function tests, particularly with clarithromycin.
* Confirm *H. pylori* eradication via stool antigen test or urea breath test after treatment completion, as per local guidelines.
## Clinical Pearls
* Administer 1 hour before meals for optimal acid suppression.
* Ensure patient is not allergic to penicillin or macrolides before prescribing.
* Complete the full course of therapy to ensure eradication and minimize resistance development.
* Consider antibiotic resistance patterns in your region when initiating therapy.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions. Dosing and indications can vary based on individual patient factors and local protocols.
